10-Q Filing

SUPERNUS PHARMACEUTICALS, INC. CIK: 1356576 Q2 2016

Filing Information

Form Type	10-Q
Accession Number	`0001104659-16-137137`
Period End Date	20160630
Filing Date	20160805
Fiscal Year	2016
Fiscal Period	Q2
XBRL Instance	supn-20160630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 83 Cash Flow Statement 62 Comprehensive Income 16

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	130.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	130.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$34.15M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$36.16M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	49.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	49.51M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$36.40M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$33.11M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$24.06M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$28.04M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	49.00M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	49.51M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$25.91M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$34.28M	USD	Point-in-time
Inventories, net	`InventoryNet`	$12.59M	USD	Point-in-time
Inventories, net	`InventoryNet`	$16.37M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.26M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.27M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$105.95M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$114.14M	USD	Point-in-time
Long term marketable securities	`MarketableSecuritiesNoncurrent`	$55.01M	USD	Point-in-time
Long term marketable securities	`MarketableSecuritiesNoncurrent`	$67.81M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.19M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.87M	USD	Point-in-time
Deferred legal fees	`DeferredCosts`	$22.50M	USD	Point-in-time
Deferred legal fees	`DeferredCosts`	$16.39M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$976.00K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$15.79M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$320.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$318.00K	USD	Point-in-time
Total assets	`Assets`	$188.63M	USD	Point-in-time
Total assets	`Assets`	$218.63M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.24M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$4.31M	USD	Point-in-time
Accrued sales deductions	`AccruedSalesDeduction`	$26.79M	USD	Point-in-time
Accrued sales deductions	`AccruedSalesDeduction`	$35.02M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$24.81M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$28.10M	USD	Point-in-time
Deferred licensing revenue	`DeferredRevenueLicensingCurrent`	$176.00K	USD	Point-in-time
Deferred licensing revenue	`DeferredRevenueLicensingCurrent`	$208.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$65.57M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$56.10M	USD	Point-in-time
Deferred licensing revenue, net of current portion	`DeferredRevenueLicensingNoncurrent`	$1.61M	USD	Point-in-time
Deferred licensing revenue, net of current portion	`DeferredRevenueLicensingNoncurrent`	$1.39M	USD	Point-in-time
Convertible notes, net	`ConvertibleLongTermNotesPayable`	$7.08M	USD	Point-in-time
Convertible notes, net	`ConvertibleLongTermNotesPayable`	$5.70M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$4.32M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$4.33M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesNoncurrent`	$412.00K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesNoncurrent`	$854.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$77.61M	USD	Point-in-time
Total liabilities	`Liabilities`	$69.75M	USD	Point-in-time
Common stock, $0.001 par value, 130,000,000 shares authorized at June 30, 2016 and December 31, 2015; 49,508,476 and 49,004,674 shares issued and outstanding at June 30, 2016 and December 31, 2015, respectively	`CommonStockValue`	$50.00K	USD	Point-in-time
Common stock, $0.001 par value, 130,000,000 shares authorized at June 30, 2016 and December 31, 2015; 49,508,476 and 49,004,674 shares issued and outstanding at June 30, 2016 and December 31, 2015, respectively	`CommonStockValue`	$49.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$270.06M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$263.95M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$549.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-488.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-144.64M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-129.64M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$118.88M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$141.02M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$188.63M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$218.63M	USD	Point-in-time

Income Statement 83 line items

Line Item	Tag	Value	Unit	Period
Net product sales	`SalesRevenueNet`	$50.34M	USD	1 Quarter
Net product sales	`SalesRevenueNet`	$93.36M	USD	2 Qtrs
Net product sales	`SalesRevenueNet`	$34.27M	USD	1 Quarter
Net product sales	`SalesRevenueNet`	$62.36M	USD	2 Qtrs
Licensing revenue	`LicensesRevenue`	$822.00K	USD	2 Qtrs
Licensing revenue	`LicensesRevenue`	$135.00K	USD	2 Qtrs
Licensing revenue	`LicensesRevenue`	$786.00K	USD	1 Quarter
Licensing revenue	`LicensesRevenue`	$86.00K	USD	1 Quarter
Total revenue	`Revenues`	$50.42M	USD	1 Quarter
Total revenue	`Revenues`	$93.50M	USD	2 Qtrs
Total revenue	`Revenues`	$63.19M	USD	2 Qtrs
Total revenue	`Revenues`	$35.05M	USD	1 Quarter
Cost of product sales	`CostOfGoodsSold`	$1.76M	USD	1 Quarter
Cost of product sales	`CostOfGoodsSold`	$4.79M	USD	2 Qtrs
Cost of product sales	`CostOfGoodsSold`	$2.75M	USD	1 Quarter
Cost of product sales	`CostOfGoodsSold`	$3.38M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$10.56M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$6.88M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$21.67M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$11.11M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$26.12M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$42.74M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$23.34M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$51.28M	USD	2 Qtrs
Total costs and expenses	`CostsAndExpenses`	$77.74M	USD	2 Qtrs
Total costs and expenses	`CostsAndExpenses`	$31.98M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$56.68M	USD	2 Qtrs
Total costs and expenses	`CostsAndExpenses`	$39.98M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$3.08M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$15.76M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$10.44M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$6.51M	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$363.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$694.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$137.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$250.00K	USD	2 Qtrs
Interest expense	`InterestExpense`	$712.00K	USD	2 Qtrs
Interest expense	`InterestExpense`	$375.00K	USD	2 Qtrs
Interest expense	`InterestExpense`	$331.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$196.00K	USD	1 Quarter
Changes in fair value of derivative liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$1.00K	USD	1 Quarter
Changes in fair value of derivative liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$224.00K	USD	2 Qtrs
Changes in fair value of derivative liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$-48.00K	USD	2 Qtrs
Changes in fair value of derivative liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$123.00K	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-382.00K	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-2.38M	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-241.00K	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-1.00K	USD	2 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$2.00K	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$25.00K	USD	2 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$25.00K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$160.00K	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-2.86M	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$292.00K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-409.00K	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$15.92M	USD	2 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.67M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$10.73M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$3.65M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$662.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$714.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$912.00K	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$724.00K	USD	2 Qtrs
Net income	`NetIncomeLoss`	$10.02M	USD	1 Quarter
Net income	`NetIncomeLoss`	$15.01M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$2.92M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$2.00M	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.20	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.30	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.04	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.06	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.06	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.18	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.28	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.03	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	49.33M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	47.91M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	46.25M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	49.43M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	51.48M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	47.69M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	52.27M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	51.75M	shares	1 Quarter

Cash Flow Statement 62 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$10.02M	USD	1 Quarter
Net income	`NetIncomeLoss`	$15.01M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$2.92M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$2.00M	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-382.00K	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-2.38M	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-241.00K	USD	1 Quarter
Change in fair value of derivative liability	`UnrealizedGainLossOnDerivatives`	$-48.00K	USD	2 Qtrs
Change in fair value of derivative liability	`UnrealizedGainLossOnDerivatives`	$224.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$431.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.12M	USD	2 Qtrs
Non-cash interest expense, net/ interest income, net	`NoncashInterestExpenseIncome`	$524.00K	USD	2 Qtrs
Non-cash interest expense, net/ interest income, net	`NoncashInterestExpenseIncome`	$405.00K	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$2.02M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$2.97M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$630.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$8.37M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$3.79M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$151.00K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.99M	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$738.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.07M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.65M	USD	2 Qtrs
Accrued sales deduction	`IncreaseDecreaseInAccruedSalesDeductions`	$8.22M	USD	2 Qtrs
Accrued sales deduction	`IncreaseDecreaseInAccruedSalesDeductions`	$7.53M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-2.25M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-1.26M	USD	2 Qtrs
Deferred licensing revenue	`IncreaseDecreaseInDeferredLicensingRevenue`	$248.00K	USD	2 Qtrs
Deferred licensing revenue	`IncreaseDecreaseInDeferredLicensingRevenue`	$-72.00K	USD	2 Qtrs
Other non-current liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-482.00K	USD	2 Qtrs
Other non-current liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-4.00K	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$13.63M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$15.17M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$23.69M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$34.27M	USD	2 Qtrs
Sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$15.66M	USD	2 Qtrs
Sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$21.86M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$903.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$777.00K	USD	2 Qtrs
Deferred legal fees	`PaymentsToAcquireIntangibleAssets`	$6.28M	USD	2 Qtrs
Deferred legal fees	`PaymentsToAcquireIntangibleAssets`	$3.69M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-19.46M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-12.63M	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$995.00K	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.01M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$995.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$1.01M	USD	2 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$2.00M	USD	2 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-3.29M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$36.40M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$33.11M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$36.16M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$34.15M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$36.40M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$33.11M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$36.16M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$34.15M	USD	Point-in-time
Cash paid for interest	`InterestPaid`	$247.00K	USD	2 Qtrs
Cash paid for interest	`InterestPaid`	$504.00K	USD	2 Qtrs
Conversion of convertible notes and interest make-whole	`DebtConversionConvertedInstrumentAndInterestMakeWholeAmount`	$25.06M	USD	2 Qtrs
Conversion of convertible notes and interest make-whole	`DebtConversionConvertedInstrumentAndInterestMakeWholeAmount`	$2.14M	USD	2 Qtrs
Deferred legal fees included in accounts payable and accrued expenses	`NonCashCapitalizedCostOfIntangibleAssets`	$5.54M	USD	2 Qtrs

Comprehensive Income 16 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$10.02M	USD	1 Quarter
Net income	`NetIncomeLoss`	$15.01M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$2.92M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$2.00M	USD	1 Quarter
Unrealized net gain (loss) on marketable securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$381.00K	USD	1 Quarter
Unrealized net gain (loss) on marketable securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$3.00K	USD	2 Qtrs
Unrealized net gain (loss) on marketable securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$1.04M	USD	2 Qtrs
Unrealized net gain (loss) on marketable securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-86.00K	USD	1 Quarter
Other comprehensive income (loss):	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$3.00K	USD	2 Qtrs
Other comprehensive income (loss):	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$381.00K	USD	1 Quarter
Other comprehensive income (loss):	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$1.04M	USD	2 Qtrs
Other comprehensive income (loss):	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-86.00K	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$10.40M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$2.93M	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$16.04M	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$1.92M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.